Dr. Davenport Show Interview With John P. Walters

Dr. Davenport Show Interview with John P. Walters – Today on The Dr. Davenport Show Guest John P. Walters Chief Operating Officer and Executive Vice President Hudson Institute, Washington, DC Headquarters As Chief Operating Officer and Executive Vice President, John Walters oversees the Institute’s operations, including staff and research management. From December 2001 to January 2009, he was director of the White House Office of National Drug Control Policy (ONDCP) and a cabinet member during the Bush Administration. As the nation’s “Drug Czar,” Mr. Walters guided all aspects of federal drug policy and programs–supporting efforts that drove down teen drug use 25 percent, increased substance abuse treatment and screening in the healthcare system and dramatically dropped the availability of cocaine and methamphetamine in the US He also helped build critical programs to counter narcoterrorism in Colombia, Mexico, and Afghanistan. From 1996 until 2001 Mr. Walters served as president of the Philanthropy Roundtable, a national association of charitable foundations and individual donors. His prior government service included work at ONDCP at its founding in 1989 as chief of staff and later deputy director of supply reduction. He was assistant to the secretary and chief of staff at the US Department of Education during the Reagan Administration. He also served in the Division of Education Programs at the National Endowment for the Humanities from 1982-1985. Mr. Walters has taught political science at Michigan State University’s …

Alameda preteen lobbies Congress on cystic fibrosis research

Filed under: drug treatment programs washington dc

As the children grew and Jeremy struggled through years of tests and treatment, his parents and siblings embraced cystic fibrosis advocacy in order to educate the public and raise money for research. By the time Bethany Kharrazi was born in 2000 …
Read more on San Jose Mercury News

NEWS SCAN: Tamiflu benefits, pertussis surge in UK, change in meningitis …

Filed under: drug treatment programs washington dc

A meta-analysis of 90 observational studies conducted during the 2009 flu pandemic showed that early neuraminidase-inhibitor (mainly oseltamivir [Tamiflu]) treatment of hospital patients reduced the risk of admission to a critical care unit or death …
Read more on CIDRAP